Etoh T - Search Results

1

Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis.

Saeki H, Kataoka Y, Etoh T, Katoh N, Teramukai S, Tajima Y, Fujita H, Ardeleanu M, Arima K. Saeki H, et al. Among authors: etoh t. Dermatol Ther (Heidelb). 2024 Feb;14(2):533-543. doi: 10.1007/s13555-023-01094-9. Epub 2024 Feb 7. Dermatol Ther (Heidelb). 2024. PMID: 38326699 Free PMC article.

2

Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study.

Ohtsuki M, Morita A, Abe M, Takahashi H, Seko N, Karpov A, Shima T, Papavassilis C, Nakagawa H; ERASURE Study Japanese subgroup. Ohtsuki M, et al. J Dermatol. 2014 Dec;41(12):1039-46. doi: 10.1111/1346-8138.12668. Epub 2014 Oct 30. J Dermatol. 2014. PMID: 25354738 Clinical Trial.

3

Long-term study of infliximab in Japanese patients with plaque psoriasis, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma.

Torii H, Nakagawa H; Japanese Infliximab Study Investigators. Torii H, et al. J Dermatol. 2011 Apr;38(4):321-34. doi: 10.1111/j.1346-8138.2010.00971.x. J Dermatol. 2011. PMID: 21544940

4

Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J).

Saeki H, Nakagawa H, Nakajo K, Ishii T, Morisaki Y, Aoki T, Cameron GS, Osuntokun OO; Japanese Ixekizumab Study Group. Saeki H, et al. J Dermatol. 2017 Apr;44(4):355-362. doi: 10.1111/1346-8138.13622. Epub 2016 Oct 11. J Dermatol. 2017. PMID: 27726163 Free PMC article. Clinical Trial.

5

Efficacy and safety of dose escalation of infliximab therapy in Japanese patients with psoriasis: Results of the SPREAD study.

Torii H, Nakano M, Yano T, Kondo K, Nakagawa H; SPREAD Study Group. Torii H, et al. J Dermatol. 2017 May;44(5):552-559. doi: 10.1111/1346-8138.13698. Epub 2016 Nov 24. J Dermatol. 2017. PMID: 27882586 Free PMC article. Clinical Trial.

6

Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: results of a randomized, vehicle-controlled, multicenter clinical trial.

Furue M, Kitahara Y, Akama H, Hojo S, Hayashi N, Nakagawa H; JAPANESE E6005 Study Investigators. Furue M, et al. J Dermatol. 2014 Jul;41(7):577-85. doi: 10.1111/1346-8138.12534. Epub 2014 Jun 18. J Dermatol. 2014. PMID: 24942594 Clinical Trial.

7

Long-term efficacy and safety results from an open-label phase III study (UNCOVER-J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab.

Umezawa Y, Torisu-Itakura H, Morisaki Y, ElMaraghy H, Nakajo K, Akashi N, Saeki H; Japanese Ixekizumab Study Group. Umezawa Y, et al. J Eur Acad Dermatol Venereol. 2019 Mar;33(3):568-576. doi: 10.1111/jdv.15292. Epub 2018 Nov 13. J Eur Acad Dermatol Venereol. 2019. PMID: 30325534 Free PMC article. Clinical Trial.

8

Effect of topical phosphodiesterase 4 inhibitor E6005 on Japanese children with atopic dermatitis: Results from a randomized, vehicle-controlled exploratory trial.

Nemoto O, Hayashi N, Kitahara Y, Furue M, Hojo S, Nomoto M, Shima S; Japanese E6005 Study Investigators. Nemoto O, et al. J Dermatol. 2016 Aug;43(8):881-7. doi: 10.1111/1346-8138.13231. Epub 2015 Dec 24. J Dermatol. 2016. PMID: 26703371 Clinical Trial.

9

Secukinumab in plaque psoriasis--results of two phase 3 trials.

Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C; ERASURE Study Group; FIXTURE Study Group. Langley RG, et al. N Engl J Med. 2014 Jul 24;371(4):326-38. doi: 10.1056/NEJMoa1314258. Epub 2014 Jul 9. N Engl J Med. 2014. PMID: 25007392 Free article. Clinical Trial.

10

Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.

Ruzicka T, Hanifin JM, Furue M, Pulka G, Mlynarczyk I, Wollenberg A, Galus R, Etoh T, Mihara R, Yoshida H, Stewart J, Kabashima K; XCIMA Study Group. Ruzicka T, et al. Among authors: etoh t. N Engl J Med. 2017 Mar 2;376(9):826-835. doi: 10.1056/NEJMoa1606490. N Engl J Med. 2017. PMID: 28249150 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

357 results

Search Page